Early investigational tubulin inhibitors as novel cancer therapeutics.
about
A 4-Phenoxyphenol Derivative Exerts Inhibitory Effects on Human Hepatocellular Carcinoma Cells through Regulating Autophagy and Apoptosis Accompanied by Downregulating α-Tubulin Expression.Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer.A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.
P2860
Early investigational tubulin inhibitors as novel cancer therapeutics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Early investigational tubulin inhibitors as novel cancer therapeutics.
@en
type
label
Early investigational tubulin inhibitors as novel cancer therapeutics.
@en
prefLabel
Early investigational tubulin inhibitors as novel cancer therapeutics.
@en
P2093
P2860
P1476
Early investigational tubulin inhibitors as novel cancer therapeutics.
@en
P2093
Hsueh-Yun Lee
Jing-Ping Liou
Kunal Nepali
P2860
P304
P356
10.1080/13543784.2016.1189901
P407
P577
2016-05-17T00:00:00Z